Clinical Trials List
2024-04-01 - 2029-12-31
Phase II
Recruiting3
ICD-10C56.1
Malignant neoplasm of right ovary
ICD-10C56.2
Malignant neoplasm of left ovary
ICD-10C56.9
Malignant neoplasm of unspecified ovary
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9183.0
Malignant neoplasm of ovary
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/16
Investigators and Locations
Co-Principal Investigator
- Ting-Chang Chang 無
- Min-Yu Chen 無
- HSIU-JUNG TUNG 無
- 周宏學 無
- 張淑涵 無
- 黃寬仁 無
- Chyong-Huey Lai 無
- 張宸邠 無
- Yun-Hsin Tang 無
- Angel Chao 無
- Cheng-Tao Lin 無
- 陳威君 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊思婷 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- BOR-CHING SHEU
- Yun Ju Huang Division of Obstetrics & Gynecology
- 楊向國
- CHI-HAU CHEN CHI-HAU CHEN
- 張文君
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
198 participants
